Clinical Trial Highlights

• Apremilast Was Associated with an Acceptable Safety Profile in ESTEEM Trials
• Selective Photothermolysis of Sebaceous Follicles with Gold Particles Rapidly Reduces Acne Lesions
• Vismodegib Improved DOR in mBCC and laBCC
• Health-Related QOL Improved with Tofacitinib in Patients with Psoriasis
• PIONEER II: Adalimumab Reduces Disease Activity in Patients with HS
• DL-PDT Not Inferior to c-PDT in Patients with AK
• IL-23 Blockade with BI 655066 Improves PASI in Psoriasis
• Safety and Efficacy of Dupilumab in Adults with Chronic AD
• Low-Dose Isotretinoin is Effective in Adult Acne Vulgaris
• Azithromycin Improved FD Symptoms
• ESTEEM 2: Apremilast Significantly Reduced Psoriasis Severity Throughout 16 Weeks
• Adapalene-BPO Reduces Acne Lesions and Scars